National Health Investors, Inc. $NHI Position Lessened by Russell Investments Group Ltd.

Key Points

• Russell Investments Group Ltd. has reduced its stake in National Health Investors, Inc. by 41.1%, selling 4,226 shares during the first quarter, resulting in a total of 6,061 shares held, valued at approximately $448,000.
• Several hedge funds have adjusted their holdings, with Allspring Global Investments increasing its stake by 15.8% and Bank of New York Mellon Corp boosting its holdings by 5.6%.
• National Health Investors recently announced a dividend increase to $0.92 per share, representing a 4.7% dividend yield, and its earnings surpassed expectations with $1.22 EPS reported against a consensus of $1.16.

Russell Investments Group Ltd. cut its holdings in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) by 41.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,061 shares of the real estate investment trust's stock after selling 4,226 shares during the quarter. Russell Investments Group Ltd.'s holdings in National Health Investors were worth $448,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. GF Fund Management CO. LTD. acquired a new stake in shares of National Health Investors in the fourth quarter valued at about $58,000. Farther Finance Advisors LLC grew its stake in shares of National Health Investors by 5,000.0% in the first quarter. Farther Finance Advisors LLC now owns 918 shares of the real estate investment trust's stock valued at $68,000 after buying an additional 900 shares in the last quarter. NewEdge Advisors LLC acquired a new stake in shares of National Health Investors in the fourth quarter valued at about $83,000. Jupiter Asset Management Ltd. acquired a new stake in shares of National Health Investors in the first quarter valued at about $206,000. Finally, Wealth Enhancement Advisory Services LLC acquired a new stake in shares of National Health Investors in the fourth quarter valued at about $226,000. 62.51% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the company. Wells Fargo & Company increased their target price on National Health Investors from $76.00 to $80.00 and gave the company an "equal weight" rating in a research note on Wednesday, August 27th. Wedbush raised National Health Investors to a "strong-buy" rating in a report on Wednesday, July 2nd. Truist Financial increased their price target on National Health Investors from $77.00 to $81.00 and gave the company a "buy" rating in a report on Friday, August 15th. Finally, KeyCorp raised National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price target for the company in a report on Thursday, July 10th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $84.20.

National Health Investors Stock Performance

NYSE:NHI traded down $0.45 during trading hours on Thursday, reaching $76.98. 45,406 shares of the stock were exchanged, compared to its average volume of 243,790. The company has a quick ratio of 10.91, a current ratio of 10.91 and a debt-to-equity ratio of 0.75. The firm has a 50 day simple moving average of $73.08 and a 200-day simple moving average of $73.07. National Health Investors, Inc. has a 52 week low of $65.13 and a 52 week high of $86.13. The stock has a market capitalization of $3.65 billion, a P/E ratio of 24.59, a P/E/G ratio of 3.36 and a beta of 0.76.

National Health Investors (NYSE:NHI - Get Free Report) last released its earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, topping analysts' consensus estimates of $1.16 by $0.06. The company had revenue of $70.27 million for the quarter, compared to the consensus estimate of $86.46 million. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.National Health Investors's quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.18 EPS. As a group, sell-side analysts forecast that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.

National Health Investors Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be issued a $0.92 dividend. This is a positive change from National Health Investors's previous quarterly dividend of $0.90. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $3.68 annualized dividend and a dividend yield of 4.8%. National Health Investors's dividend payout ratio (DPR) is 115.02%.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.